3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Quality of Life
2
Drug Therapy
2
Blood Specimen Collection
2
Tumor Burden
1
Syndecan-1
1
Patient Reported Outcome Measures
1
Oxaliplatin
1
Osteopontin
1
Observation
1
Molecular Diagnostic Techniques
1
Mitoxantrone
1
Mesothelin
1
Leucovorin
1
Immunotherapy
1
Ifosfamide
1
Hyaluronic Acid
1
Histocompatibility Testing
1
Fluorouracil
1
Doxorubicin
1
Data Collection
1
Comparative Genomic Hybridization
1
Cisplatin
1
Blood Component Removal
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Mesothelioma
×
Blood Component Removal
×
Clear all
NCT04981119
2026-04-30
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
200 enrolled